For example, both agonists studied induced significant changes in phosphorylation sites of SEPT5 and FERMT3, and deficiency of these proteins causes bleeding disorders associated with platelet defects [41], [42]. The gene discussed is SEPTIN5; the disease is hemorrhagic disease.